LEPRE1 blocking peptide
LEPRE1 Blocking Peptide (Center)
NCBI and Uniprot Product Information
NCBI Description
This gene encodes an enzyme that is a member of the collagen prolyl hydroxylase family. These enzymes are localized to the endoplasmic reticulum and their activity is required for proper collagen synthesis and assembly. Mutations in this gene are associated with osteogenesis imperfecta type VIII. Three alternatively spliced transcript variants encoding different isoforms have been described. Other variants may exist, but their biological validity has not been determined. [provided by RefSeq, Aug 2011]
Uniprot Description
LEPRE1: Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro- Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts. Defects in LEPRE1 are the cause of osteogenesis imperfecta type 8 (OI8). A connective tissue disorder characterized by disproportionate short stature, severe osteoporosis, shortening of the long bones, white sclerae, a round face and a short barrel-shaped chest. Belongs to the leprecan family. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: EC 1.14.11.7; Secreted, signal peptide; Oxidoreductase; Cell development/differentiation; Secreted
Chromosomal Location of Human Ortholog: 1p34.1
Cellular Component: endoplasmic reticulum; endoplasmic reticulum lumen; membrane
Molecular Function: collagen binding; procollagen-proline 3-dioxygenase activity; protein complex binding
Biological Process: collagen metabolic process; protein amino acid hydroxylation; protein folding; protein stabilization; regulation of protein secretion
Disease: Osteogenesis Imperfecta, Type Viii